- Citations, last 5 years
- 356.5k
- Works, last 5 years
- 25.4k
- h-index
- 1,797
- Scientists listed
- 655
- Grants since 2016
- 3 144
Grants received
1997–2025 · program · P01
Development of Novel Therapeutic Strategies in Human Leukemias
Benjamin Levine Ebert · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2021 · program · P30
Dana-Farber/Harvard Cancer Center
Laurie Hollis Glimcher · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2021 · program · P30
Dana-Farber/Harvard Cancer Center
Laurie Hollis Glimcher · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2021 · program · P30
Dana-Farber/Harvard Cancer Center
Laurie Hollis Glimcher · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2026 · program · P30
The Dana-Farber/Harvard Cancer Center Bioethics Research Initiative
Laurie Hollis Glimcher · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2025 · program · P01
Development of Novel Therapeutic Strategies in Human Leukemias
Benjamin Levine Ebert · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2026 · program · P01
Development of Novel Therapeutic Strategies in Human Leukemias
Benjamin Levine Ebert · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2021 · program · P30
Project Glioblastoma CARE: Cellular Analysis of Resistance and Evolution (2)
Laurie Hollis Glimcher · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2020 · program · P30
Dana-Farber/Harvard Cancer Center
Laurie Hollis Glimcher · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2026 · research · R01
Polyploidy, Aneuploidy and Genome Stability
David S Pellman · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2025 · program · P01
Development of Novel Therapeutic Strategies in Human Leukemias
Benjamin Levine Ebert · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2021 · program · P30
Dana-Farber/Harvard Cancer Center
Laurie Hollis Glimcher · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2021 · program · P30
Dana-Farber/Harvard Cancer Center
Laurie Hollis Glimcher · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2020 · program · P30
Dana-Farber/Harvard Cancer Center
Laurie Hollis Glimcher · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2021 · program · P30
Creating an Efficient Clinical Trial Build System Via the Clinical Trials Rapid Activation Consortium (CTRAC)
Laurie Hollis Glimcher · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2021 · program · P30
Dana-Farber/Harvard Cancer Center
Laurie Hollis Glimcher · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2021 · research · R01
Polyploidy, aneuploidy, and genome stability
David S Pellman · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2021 · program · P30
Administrative Supplements to Cancer Center Support Grants to Strengthen NCI-Supported Community Outreach Capacity Through Community Health Educators of the National Outreach Network (2)
Laurie Hollis Glimcher · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2021 · program · P30
Dana-Farber/Harvard Cancer Center
Laurie Hollis Glimcher · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2021 · research · R01
Polyploidy, aneuploidy, and genome stability
David S Pellman · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2021 · program · P30
Dana-Farber/Harvard Cancer Center
Laurie Hollis Glimcher · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2020 · program · P30
Dana-Farber/Harvard Cancer Center
Laurie Hollis Glimcher · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2021 · program · P30
Dana-Farber/Harvard Cancer Center
Laurie Hollis Glimcher · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2021 · program · P30
Dana-Farber/Harvard Cancer Center
Laurie Hollis Glimcher · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2025 · program · P01
Development of Novel Therapeutic Strategies in Human Leukemias
Benjamin Levine Ebert · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2021 · program · P30
Dana-Farber/Harvard Cancer Center
Laurie Hollis Glimcher · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2020 · program · P30
Dana-Farber/Harvard Cancer Center
Laurie Hollis Glimcher · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2021 · program · P30
Dana-Farber/Harvard Cancer Center
Laurie Hollis Glimcher · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2021 · program · P30
Dana-Farber/Harvard Cancer Center
Laurie Hollis Glimcher · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2021 · program · P30
Dana-Farber/Harvard Cancer Center
Laurie Hollis Glimcher · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2021 · program · P30
Dana-Farber/Harvard Cancer Center
Laurie Hollis Glimcher · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2021 · program · P30
Dana-Farber/Harvard Cancer Center
Laurie Hollis Glimcher · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2026 · program · P30
Dana-Farber/Harvard Cancer Center
Benjamin Levine Ebert · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2021 · program · P30
Dana-Farber/Harvard Cancer Center
Laurie Hollis Glimcher · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2021 · program · P30
Dana-Farber/Harvard Cancer Center
Laurie Hollis Glimcher · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2026 · program · P30
Administrative Supplements to Participate in the NCI Early-stage Surgeon Scientist Program (ESSP)
Laurie Hollis Glimcher · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2021 · research · R01
Polyploidy, aneuploidy, and genome stability
David S Pellman · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2021 · program · P30
Dana-Farber/Harvard Cancer Center
Laurie Hollis Glimcher · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2021 · research · R01
Polyploidy, aneuploidy, and genome stability
David S Pellman · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2021 · program · P30
Dana-Farber/Harvard Cancer Center
Laurie Hollis Glimcher · Dana-Farber Cancer Institute · funded by National Institutes of Health
